Cancers in cyclosporine-treated vs azathioprine-treated patients.
Penn
I
I
Department of Surgery, University of Cincinnati Medical Center, Ohio 45267-0558, USA.
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use*; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000453:epidemiology; D016030:Kidney Transplantation / Q000276:immunology; D008048:Lip Neoplasms / Q000453:epidemiology; D008223:Lymphoma / Q000453:epidemiology; D009369:Neoplasms / Q000453:epidemiology*; D012514:Sarcoma, Kaposi / Q000453:epidemiology; D012878:Skin Neoplasms / Q000453:epidemiology; D014181:Transplantation Immunology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology; D014846:Vulvar Neoplasms / Q000453:epidemiology
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine